The world of financing life-science companies has changed radically since 2001. This reality makes it difficult for new and emerging companies, as they analyze past trends, to figure out how to raise money. The rules have changed!
Let's start with the Initial Public Offering (IPO) market, which is how many investors used to make money (those that had inves......Full article >>>
on the serial entrepreneur that previously made money for the investor. Start-up and seed-stage financing by VCs has been like the magician's disappearing act.
This situation would call for an immediate cry of alarm if it weren't for other financing phenomena:
The increased amount of money that both Big Pharma and Big (and medium-sized) Biotech......Full article >>>
terhouseCoopers MoneyTree report, $6.2 billion of venture money funded 797 deals during the third quarter of 2006, or an average of $7.8 billion per deal. This amount was eight percent lower than the amount in the second quarter, $6.8 billion which funded 907 deals (or an average of $7.5 million per deal), but still broke the $6 billion level for the third consecutive quarter.
Full article >>>
with an average deal size of $4.5 million.
For the first time, the report identified American VC investment in international companies:
$221 million in 18 Chinese companies ($12.3 million per company).
$203 million in 18 Indian companies ($11.3 million per company).
$46 million in 11 Israeli companies ($4.2 million per company).
Full article >>>
| Sacramento/N. California|| $20|| +186%|| 2|| $10|
| South Central|| $10|| <74%>|| 5|| $2|
| Other|| $1|| <50%>|| 2|| $.5|
Source: PriceWaterhouseCooper's MoneyTree Report - Third Quarter, 2006
Wonder of all wonders: C......Full article >>>
n also is a founder and board member of the Illinois Biotechnology Industry Organization
. He can be reached at email@example.com
The opinions expressed herein or statements made in the above column are solely those of the author and do not necessarily reflect the views of The Wisconsin Technology Network, L......Full article >>>
Source:wistechnology.com By Michael Rosen 12/04/06Related biology technology :1
. Financing of biotech companies so far in 2005: A Midwest odyssey2
. Seed-Stage Venture Financing3
. Quintessence Secures Financing4
. Food science: increasing crop yields